Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study
- PMID: 18031707
- DOI: 10.1016/S1474-4422(07)70291-0
Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study
Abstract
The main neurological causes of morbidity and mortality are stroke and dementia. We contend that the most relevant and readily communicated risk estimate for stroke and dementia is lifetime risk, which is the probability of someone of a given age and sex developing a condition during their remaining lifespan. Lifetime risk estimates describe the population burden; however, they can be refined with risk-stratified models to enable individual risk prediction. Community-based data on a group of North Americans of European descent indicate that the lifetime risk of stroke for a middle-aged woman is 1 in 5 and for a middle-aged man is 1 in 6. The lifetime risk of stroke was equal to the lifetime risk of dementia and equal to or greater than the lifetime risk of Alzheimer's disease (1 in 5 and 1 in 10 for women and men, respectively), and the lifetime risk of stroke or dementia was greater than 1 in 3. Thus, the lifetime burden attributable to common neurological disease is immense.
Similar articles
-
Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study.Neurology. 1997 Dec;49(6):1498-504. doi: 10.1212/wnl.49.6.1498. Neurology. 1997. PMID: 9409336
-
Lifetime risk of common neurological diseases in the elderly population.J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):148-156. doi: 10.1136/jnnp-2018-318650. Epub 2018 Oct 2. J Neurol Neurosurg Psychiatry. 2019. PMID: 30279211
-
The lifetime risk of stroke: estimates from the Framingham Study.Stroke. 2006 Feb;37(2):345-50. doi: 10.1161/01.STR.0000199613.38911.b2. Epub 2006 Jan 5. Stroke. 2006. PMID: 16397184
-
Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.Lancet Neurol. 2009 Nov;8(11):1006-18. doi: 10.1016/S1474-4422(09)70236-4. Epub 2009 Sep 24. Lancet Neurol. 2009. PMID: 19782001 Review.
-
Brain health and shared risk factors for dementia and stroke.Nat Rev Neurol. 2015 Nov;11(11):651-7. doi: 10.1038/nrneurol.2015.195. Epub 2015 Oct 20. Nat Rev Neurol. 2015. PMID: 26481296 Review.
Cited by
-
Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the cardiovascular lifetime risk pooling project.Circulation. 2012 Jan 3;125(1):37-44. doi: 10.1161/CIRCULATIONAHA.110.002774. Epub 2011 Dec 19. Circulation. 2012. PMID: 22184621 Free PMC article.
-
Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.CNS Drugs. 2015 Feb;29(2):113-30. doi: 10.1007/s40263-015-0230-6. CNS Drugs. 2015. PMID: 25700645 Review.
-
Divergence and Convergence of Sex-Specific Time Trends in Ischemic Stroke: 10-Year Analysis of a State-Wide Registry in Germany.J Am Heart Assoc. 2022 Oct 18;11(20):e027130. doi: 10.1161/JAHA.122.027130. Epub 2022 Oct 17. J Am Heart Assoc. 2022. PMID: 36250659 Free PMC article.
-
Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.Acta Neuropathol Commun. 2018 Sep 24;6(1):100. doi: 10.1186/s40478-018-0603-4. Acta Neuropathol Commun. 2018. PMID: 30249297 Free PMC article.
-
Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly.Int J Environ Res Public Health. 2021 Dec 25;19(1):207. doi: 10.3390/ijerph19010207. Int J Environ Res Public Health. 2021. PMID: 35010467 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical